Patent · US Active

N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity

US10604511B2 · kind B2 · utility

0Cited by

2References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Doris Riether · Biberach an der Riß, DE
Marco Ferrara · San Donato Milanese, IT
Niklas Heine · Eberhardzell, DE
Uta Friederike Lessel · Maselheim, DE
Janet Rachel Nicholson · Oberhofen, DE
Anton Pekcec · Munich, DE

Key dates

Filing date	Apr 7, 2017
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Apr 7, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to compounds of formula I a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2 and R3 have meanings given in the description.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.